|
Market Closed -
Xetra
11:35:38 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 19.80 EUR | -0.20% |
|
-3.88% | -22.66% |
| 08-26 | Formycon AG : Berenberg reaffirms its Buy rating | ZD |
| 08-12 | Formycon AG, H1 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 405M | |||||
| 45.91B | |||||
| 44.25B | |||||
| 41.99B | - | - | - | - | - |
| 39.58B | |||||
| 31.08B |
- Stock Market
- Stocks
- FYB Stock
- Charts Formycon AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
